Linked Life Data

1561669

Source:http://linkedlifedata.com/resource/pubmed/id/1561669

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2 Suppl
pubmed:dateCreated
1992-5-11
pubmed:abstractText
Antiphospholipid antibodies have been reported to occur in ischemic stroke patients. We review the major epidemiological study designs and measures of risk and discuss these concepts in relation to the assessment of antiphospholipid antibodies as a risk factor for ischemic stroke. While there have been few rigorously designed epidemiological studies, available data suggest that the stroke risk associated with antiphospholipid antibodies may be substantial, especially in young adults. Additional epidemiological studies are needed to establish the consistency of this relation. A well-designed clinical trial could answer important questions about the efficacy and safety of proposed treatments.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0039-2499
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
I19-22
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Antiphospholipid antibodies and stroke: an epidemiological perspective.
pubmed:affiliation
Department of Neurology, University of Maryland, Baltimore.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't